Mirati Therapeutics (MRTX) stock Forecast for 2021 – 2025

Mirati Therapeutics (MRTX) stock Forecast for 2022 – 2026

Last update: 05-20-2022, 7:09

Sector: Healthcare

The share price of Mirati Therapeutics, Inc. (MRTX) now

What analysts predict:: $148.64

52-week high/low: $195.99 / $51.16

50/200 Day Moving Average: $75.55 / $127.29

This figure corresponds to the average price over the previous 50/200 days. For Mirati Therapeutics stocks, the 50-day moving average is the resistance level today.

For Mirati Therapeutics stocks, the 200-day moving average is the resistance level today.

Are you interested in Mirati Therapeutics, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Mirati Therapeutics stock price in 2022, 2023, 2024, 2025, 2026. How much will one Mirati Therapeutics share be worth in 2022 - 2026?

When should I take profit in Mirati Therapeutics stock? When should I record a loss on Mirati Therapeutics stock? What are analysts' forecasts for Mirati Therapeutics stock? What is the future of Mirati Therapeutics stock?

We forecast Mirati Therapeutics stock performance using neural networks based on historical data on Mirati Therapeutics stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

Mirati Therapeutics stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2022, 2023, 2024, 2025 and 2026)

The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Mirati Therapeutics shares. This happens once a day.




Historical and forecast chart of Mirati Therapeutics stock

The chart below shows the historical price of Mirati Therapeutics stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Mirati Therapeutics stock price can be found in the table below.

Long-term forecasts by years.

Mirati Therapeutics daily forecast for a month

Date Target Pes. Opt. Vol., %
May 22 61.10 60.40 61.79 2.30
May 23 60.89 59.63 62.23 4.36
May 24 58.99 57.98 60.23 3.88
May 25 59.36 58.57 60.51 3.30
May 26 58.82 57.57 59.79 3.86
May 27 60.24 58.77 61.59 4.81
May 28 59.44 58.53 60.34 3.09
May 29 59.01 57.83 60.51 4.64
May 30 60.39 58.70 61.15 4.18
May 31 59.40 58.50 60.56 3.52
Jun 01 57.84 57.23 58.49 2.19
Jun 02 58.93 58.00 60.04 3.52
Jun 03 59.34 58.14 60.44 3.97
Jun 04 59.03 58.56 60.35 3.07
Jun 05 60.13 59.47 61.64 3.64
Jun 06 60.34 59.45 60.82 2.31
Jun 07 61.63 60.46 62.79 3.85
Jun 08 60.76 60.34 62.40 3.42
Jun 09 61.44 60.09 62.37 3.79
Jun 10 60.11 59.50 61.77 3.82
Jun 11 60.43 60.00 61.57 2.61
Jun 12 58.75 58.04 59.37 2.30
Jun 13 60.05 59.44 60.64 2.02
Jun 14 61.65 60.74 62.99 3.69
Jun 15 63.31 62.80 64.33 2.43
Jun 16 64.31 63.23 65.45 3.52
Jun 17 63.00 62.03 63.86 2.95
Jun 18 62.27 61.49 63.56 3.37
Jun 19 62.25 61.60 63.65 3.32
Jun 20 60.66 60.11 61.53 2.37

Mirati Therapeutics Daily Price Targets


Mirati Therapeutics Stock Forecast 05-22-2022.

Forecast target price for 05-22-2022: $61.10. Positive dynamics for Mirati Therapeutics shares will prevail with possible volatility of 2.250%.

Pessimistic target level: 60.40

Optimistic target level: 61.79


Mirati Therapeutics Stock Forecast 05-23-2022.

Forecast target price for 05-23-2022: $60.89. Negative dynamics for Mirati Therapeutics shares will prevail with possible volatility of 4.178%.

Pessimistic target level: 59.63

Optimistic target level: 62.23


Mirati Therapeutics Stock Forecast 05-24-2022.

Forecast target price for 05-24-2022: $58.99. Negative dynamics for Mirati Therapeutics shares will prevail with possible volatility of 3.737%.

Pessimistic target level: 57.98

Optimistic target level: 60.23


Mirati Therapeutics Stock Forecast 05-25-2022.

Forecast target price for 05-25-2022: $59.36. Positive dynamics for Mirati Therapeutics shares will prevail with possible volatility of 3.194%.

Pessimistic target level: 58.57

Optimistic target level: 60.51


Mirati Therapeutics Stock Forecast 05-26-2022.

Forecast target price for 05-26-2022: $58.82. Negative dynamics for Mirati Therapeutics shares will prevail with possible volatility of 3.719%.

Pessimistic target level: 57.57

Optimistic target level: 59.79


Mirati Therapeutics Stock Forecast 05-27-2022.

Forecast target price for 05-27-2022: $60.24. Positive dynamics for Mirati Therapeutics shares will prevail with possible volatility of 4.587%.

Pessimistic target level: 58.77

Optimistic target level: 61.59


MRTX (MRTX) Monthly Stock Prediction for 2022

Month Target Pes. Opt. Vol., %
Jun. 55.79 52.70 61.06 13.70
Jul. 57.97 52.58 63.01 16.56
Aug. 60.32 54.71 63.21 13.45
Sep. 51.99 47.39 55.89 15.21
Oct. 48.09 43.04 52.64 18.23
Nov. 49.90 43.98 52.52 16.25
Dec. 48.92 46.80 50.61 7.54

Mirati Therapeutics forecast for this year


Mirati Therapeutics Stock Prediction for Jun 2022

An downtrend is forecast for this month with an optimal target price of $55.7924. Pessimistic: $52.70. Optimistic: $61.06


Mirati Therapeutics Stock Prediction for Jul 2022

An uptrend is forecast for this month with an optimal target price of $57.9683. Pessimistic: $52.58. Optimistic: $63.01


Mirati Therapeutics Stock Prediction for Aug 2022

An uptrend is forecast for this month with an optimal target price of $60.316. Pessimistic: $54.71. Optimistic: $63.21


Mirati Therapeutics Stock Prediction for Sep 2022

An downtrend is forecast for this month with an optimal target price of $51.9924. Pessimistic: $47.39. Optimistic: $55.89


Mirati Therapeutics Stock Prediction for Oct 2022

An downtrend is forecast for this month with an optimal target price of $48.0929. Pessimistic: $43.04. Optimistic: $52.64


Mirati Therapeutics Stock Prediction for Nov 2022

An uptrend is forecast for this month with an optimal target price of $49.8964. Pessimistic: $43.98. Optimistic: $52.52


Mirati Therapeutics Stock Prediction for Dec 2022

An downtrend is forecast for this month with an optimal target price of $48.9235. Pessimistic: $46.80. Optimistic: $50.61




Mirati Therapeutics (MRTX) Monthly Stock Prediction for 2023

Month Target Pes. Opt. Vol., %
Jan 45.69 43.30 49.12 11.86
Feb 48.30 42.50 49.75 14.56
Mar 46.71 41.24 48.18 14.40
Apr 43.20 40.61 47.41 14.35
May 44.04 41.07 46.89 12.40
Jun 47.08 45.39 50.40 9.95
Jul 51.11 47.97 55.63 13.78
Aug 55.02 48.75 60.71 19.71
Sep 51.88 46.75 53.52 12.65
Oct 58.89 56.06 65.42 14.31
Nov 64.98 57.96 69.17 16.20
Dec 74.53 71.40 79.79 10.51

Mirati Therapeutics (MRTX) Monthly Stock Prediction for 2024

Month Target Pes. Opt. Vol., %
Jan 73.19 69.68 78.35 11.07
Feb 77.26 70.77 84.56 16.31
Mar 79.92 73.81 85.68 13.85
Apr 71.65 64.66 77.45 16.51
May 72.51 69.68 79.36 12.20
Jun 68.38 64.68 76.58 15.54
Jul 66.84 59.12 74.76 20.92
Aug 70.55 65.15 73.62 11.50
Sep 72.13 67.91 76.35 11.05
Oct 62.40 58.37 67.26 13.22
Nov 65.02 59.85 71.94 16.81
Dec 67.45 59.46 71.91 17.31



Mirati Therapeutics (MRTX) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Jan 76.76 68.36 85.28 19.85
Feb 77.80 68.58 80.60 14.91
Mar 82.47 77.15 84.94 9.17
Apr 87.66 84.38 97.53 13.48
May 84.77 78.29 87.31 10.34
Jun 78.41 75.00 83.82 10.52
Jul 78.29 74.42 86.87 14.33
Aug 77.36 70.51 82.93 14.97
Sep 73.99 69.22 77.65 10.86
Oct 69.44 66.42 75.27 11.76
Nov 67.88 65.43 72.66 9.95
Dec 69.40 65.14 72.01 9.54

Mirati Therapeutics (MRTX) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 74.71 72.02 80.54 10.58
Feb 78.08 74.68 86.39 13.56
Mar 80.18 71.52 89.21 19.82
Apr 83.55 77.41 86.94 10.96
May 80.54 76.44 90.09 15.15
Jun 78.97 72.34 86.67 16.54
Jul 83.71 78.06 91.62 14.80
Aug 89.49 79.29 92.71 14.48
Sep 87.74 83.01 97.22 14.62
Oct 83.40 77.15 87.03 11.36
Nov 72.02 66.72 74.50 10.44
Dec 61.97 55.65 67.92 18.07

Mirati Therapeutics information and performance

Mirati Therapeutics, Inc. is a clinical stage biopharmaceutical company. The company is focused on developing a pipeline of targeted cancer drugs. The company is developing candidate products to combat genetic and immunological cancer promoters. Its clinical programs consist of two candidate products: MRTX849, a Kirsten rat sarcoma inhibitor (KRAS) G12C, and Sitravatinib, a multi-kinase inhibitor. His KRAS inhibitor program is focused on the discovery and development of small molecule compounds that target KRAS G12C and G12D. MRTX849 is designed to inhibit the KRAS G12C mutations that are present in patients with non-small cell lung cancer (NSCLC), adenocarcinoma, colorectal cancer (CRC), pancreatic cancer, and several other intractable cancers. Sitravatinib is a spectrally selective kinase inhibitor designed to inhibit receptor tyrosine kinases (RTKs) including TAM family receptors (TYRO3, Axl, Mer), split family receptors (VEGFR2, KIT) and RET.

Mirati Therapeutics Address

9393 TOWNE CENTRE DRIVE, SUITE 200, SAN DIEGO, CA, US

Market Capitalization: 3 156 149 000 $

Market capitalization is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of shares in the company outstanding by the market price of one share.

EBITDA: -148 816 000 $

EBITDA is earnings before interest, income tax and depreciation of assets.

PE Ratio: None

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: N/A

Price/earnings to growth

DPS: N/A

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: N/A

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: -11.21

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: N/A

Quarterly Revenue Growth YOY: -0.825

Trailing PE: -

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: -

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 25.76

Enterprise Value (EV) /Revenue

EV To EBITDA: -

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 55527000

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A

Percent Insiders: N/A

Percent Institutions: N/A




Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.